View Financial HealthNutrien 配当と自社株買い配当金 基準チェック /36Nutrienは配当を支払う会社で、現在の利回りは3.38%ですが、利益によって十分にカバーされています。次の支払い日は 17th July, 2026で、権利落ち日は30th June, 2026 。主要情報3.4%配当利回り1.5%バイバック利回り総株主利回り4.9%将来の配当利回り3.5%配当成長8.1%次回配当支払日17 Jul 26配当落ち日30 Jun 26一株当たり配当金n/a配当性向44%最近の配当と自社株買いの更新Declared Dividend • May 11First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2026 Payment date: 17th July 2026 Dividend yield will be 3.2%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 15% over the next 3 years. However, it would need to fall by 51% to increase the payout ratio to a potentially unsustainable range.Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 16 April 2026. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (1.8%).Declared Dividend • Feb 22Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2026 Payment date: 16th April 2026 Dividend yield will be 3.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (47% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 5.2% over the next 3 years. However, it would need to fall by 48% to increase the payout ratio to a potentially unsustainable range.Upcoming Dividend • Sep 22Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 17 October 2025. Payout ratio is on the higher end at 78%, however this is supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (2.0%).Declared Dividend • Aug 10Second quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 29th September 2025 Payment date: 17th October 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 33% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Aug 07+ 1 more updateNutrien Declares Quarterly Dividend, Payable on October 17, 2025Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025.すべての更新を表示Recent updatesBuy Or Sell Opportunity • Jun 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to US$67.20. The fair value is estimated to be US$84.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.3% per annum. Earnings are forecast to decline by 6.9% per annum over the same time period.Recent Insider Transactions • May 14Independent Director recently bought US$999k worth of stockOn the 8th of May, Aaron Regent bought around 14k shares on-market at roughly US$68.93 per share. This transaction amounted to 61% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$2.0m more in shares than they have sold in the last 12 months.Declared Dividend • May 11First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2026 Payment date: 17th July 2026 Dividend yield will be 3.2%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 15% over the next 3 years. However, it would need to fall by 51% to increase the payout ratio to a potentially unsustainable range.Seeking Alpha • May 10Nutrien: Fertilizer Demand Isn't Going Anywhere, And The Market Is Undervaluing ItSummary Nutrien is mispriced as the market overweights European sustainability policy, ignoring surging synthetic fertilizer demand in emerging markets. NTR's integrated model, record 2025 EBITDA of $6.05B, and 14x forward P/E position it for structural demand growth, not decline. Key catalysts include Q1 2026 earnings, potash price stabilization, and continued retail expansion in Brazil and other developing regions. Risks include fertilizer price volatility, natural gas cost swings, and execution risk in emerging markets, particularly Brazil. Read the full article on Seeking AlphaReported Earnings • May 07First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.27 (up from US$0.022 in 1Q 2025). Revenue: US$5.80b (up 19% from 1Q 2025). Net income: US$131.0m (up US$120.0m from 1Q 2025). Profit margin: 2.3% (up from 0.2% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) missed analyst estimates by 47%. Revenue is forecast to stay flat during the next 3 years compared to a 5.2% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Buy Or Sell Opportunity • May 06Now 23% undervaluedOver the last 90 days, the stock has risen 8.6% to US$73.81. The fair value is estimated to be US$96.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 2.1% per annum over the same time period.お知らせ • Apr 10Nutrien Ltd. to Report Q1, 2026 Results on May 06, 2026Nutrien Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026Buy Or Sell Opportunity • Apr 08Now 21% undervaluedOver the last 90 days, the stock has risen 25% to US$74.88. The fair value is estimated to be US$94.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.1% per annum. Earnings are forecast to decline by 1.9% per annum over the same time period.Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 16 April 2026. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (1.8%).Buy Or Sell Opportunity • Mar 20Now 20% undervaluedOver the last 90 days, the stock has risen 20% to US$74.73. The fair value is estimated to be US$93.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 0.9% per annum over the same time period.New Risk • Mar 18New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.Recent Insider Transactions • Mar 17Insider recently sold US$403k worth of stockOn the 11th of March, Christopher Reynolds sold around 5k shares on-market at roughly US$83.96 per share. This transaction amounted to 37% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$328k more than they sold in the last 12 months.New Risk • Mar 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.Buy Or Sell Opportunity • Mar 04Now 21% undervaluedOver the last 90 days, the stock has risen 23% to US$73.59. The fair value is estimated to be US$92.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.6% per annum. Earnings are forecast to decline by 0.02% per annum over the same time period.お知らせ • Feb 23Nutrien Ltd., Annual General Meeting, May 06, 2026Nutrien Ltd., Annual General Meeting, May 06, 2026.Declared Dividend • Feb 22Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2026 Payment date: 16th April 2026 Dividend yield will be 3.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (47% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 5.2% over the next 3 years. However, it would need to fall by 48% to increase the payout ratio to a potentially unsustainable range.Reported Earnings • Feb 19Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: US$4.66 (up from US$1.36 in FY 2024). Revenue: US$25.9b (up 3.7% from FY 2024). Net income: US$2.27b (up 236% from FY 2024). Profit margin: 8.7% (up from 2.7% in FY 2024). The increase in margin was primarily driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 9.0%. Revenue is forecast to grow 1.3% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.お知らせ • Feb 19+ 1 more updateNutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects,Potash sales volume guidance of 14.1 million tonnes to 14.8 million tonnes is consistent with our global shipment expectation. Nitrogen sales volume guidance of 9.2 million tonnes to 9.7 million tonnes assumes no production from our Trinidad and New Madrid facility, which accounted for approximately 1.4 million tonnes and 0.2 million tonnes, respectively, in 2025. Nitrogen sales volumes are supported by planned reliability improvements and debottlenecks. Phosphate sales volume guidance of 2.4 million tonnes to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.New Risk • Feb 04New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.5% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity).New Risk • Jan 21New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.6% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity).Board Change • Jan 21Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jan 21Nutrien Ltd. to Report Q4, 2025 Results on Feb 18, 2026Nutrien Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026お知らせ • Dec 12Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR).Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd. Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) on December 10, 2025.お知らせ • Nov 06+ 1 more updateNutrien Ltd. Revises Operating Guidance for the Fiscal Year 2025Nutrien Ltd. revised operating guidance for the fiscal year 2025. For the year, the company expects Potash sales volumes to be in the range of 14 million tonnes to 14.5 million tonnes compared to previous guidance of 13.9 million tonnes to 14.5 million tonnes. Nitrogen sales volumes to be in the range of 10.7 million tonnes to 11 million tonnes compared to previous guidance of 10.7 million tonnes to 11.2 million tonnes. Phosphate sales volumes to be in the range of 2.35 million tonnes to 2.55 million tonnes compared to previous guidance of 2.35 million tonnes to 2.55 million tonnes.お知らせ • Oct 22+ 1 more updateNutrien Ltd. Commences A Controlled Shut Down of Its Trinidad Nitrogen OperationsNutrien Ltd. announced that it has commenced a controlled shut down of its Trinidad Nitrogen operations at the Point Lisas' facility to be effective October 23, 2025. This shutdown is in response to port access restrictions imposed by Trinidad and Tobago's National Energy Corporation (NEC) and a lack of reliable and economic natural gas supply that has reduced the free cash flow contribution of the Trinidad Nitrogen operations over an extended period of time. Nutrien will continue to engage with stakeholders and assess options with respect to its operations in Trinidad. Ammonia and urea sales volumes from Nutrien's Trinidad operations are approximately 85 and 55 thousand tonnes per month, respectively. Nutrien expects to be within its 2025 annual nitrogen sales volume guidance range of 10.7 to 11.2 million tonnes due to the continued strong performance of its North American Nitrogen operations.Buy Or Sell Opportunity • Oct 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.0% to US$56.42. The fair value is estimated to be US$71.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 82%. For the next 3 years, revenue is forecast to grow by 2.2% per annum. Earnings are also forecast to grow by 14% per annum over the same time period.お知らせ • Oct 07Nutrien Ltd. to Report Q3, 2025 Results on Nov 05, 2025Nutrien Ltd. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025Upcoming Dividend • Sep 22Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 17 October 2025. Payout ratio is on the higher end at 78%, however this is supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (2.0%).お知らせ • Sep 09Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million.Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd.Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Declared Dividend • Aug 10Second quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 29th September 2025 Payment date: 17th October 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 33% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Aug 07Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2025 results: EPS: US$2.51 (up from US$0.78 in 2Q 2024). Revenue: US$10.2b (up 2.8% from 2Q 2024). Net income: US$1.22b (up 217% from 2Q 2024). Profit margin: 12% (up from 3.9% in 2Q 2024). The increase in margin was primarily driven by lower expenses. Revenue missed analyst estimates by 2.4%. Earnings per share (EPS) exceeded analyst estimates by 10%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.お知らせ • Aug 07+ 1 more updateNutrien Declares Quarterly Dividend, Payable on October 17, 2025Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025.Buy Or Sell Opportunity • Aug 06Now 20% undervaluedOver the last 90 days, the stock has risen 5.8% to US$57.95. The fair value is estimated to be US$72.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 73%. For the next 3 years, revenue is forecast to grow by 2.4% per annum. Earnings are also forecast to grow by 23% per annum over the same time period.お知らせ • Jul 10Nutrien Ltd. to Report Q2, 2025 Results on Aug 06, 2025Nutrien Ltd. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2025. Payment date: 18 July 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.6%. Lower than top quartile of American dividend payers (4.8%). Higher than average of industry peers (2.2%).Declared Dividend • May 11First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2025 Payment date: 18th July 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (202% earnings payout ratio) nor is it covered by cash flows (127% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 125% to bring the payout ratio under control. EPS is expected to grow by 108% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.New Risk • May 09New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Dividend yield: 3.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Minor Risks High level of debt (52% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).Reported Earnings • May 08First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: US$0.022 (down from US$0.32 in 1Q 2024). Revenue: US$4.87b (down 5.4% from 1Q 2024). Net income: US$11.0m (down 93% from 1Q 2024). Profit margin: 0.2% (down from 3.1% in 1Q 2024). Revenue missed analyst estimates by 5.3%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.お知らせ • May 08+ 1 more updateNutrien Ltd. Provides Operation Guidance for the Year 2025Nutrien Ltd. provided operation guidance for the year 2025. For the year, the company provided Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with its historical share of global shipments. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes reliability improvements and higher operating rates at its North American plants compared to 2024. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production in the first half of 2025 and improved operating rates in the second half compared to the prior year.お知らせ • Apr 16Nutrien Ltd. to Report Q1, 2025 Results on May 07, 2025Nutrien Ltd. announced that they will report Q1, 2025 results After-Market on May 07, 2025Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2025. Payment date: 10 April 2025. The company is paying out more than 100% of its profits and is paying out 77% of its cash flow. Trailing yield: 4.2%. Lower than top quartile of American dividend payers (4.7%). Higher than average of industry peers (2.2%).お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 07, 2025Nutrien Ltd., Annual General Meeting, May 07, 2025.Seeking Alpha • Feb 24Nutrien: The Downtrend Is Done, Dividend Hike And Technicals Are EvidenceSummary The Materials sector, particularly the agricultural industry, has outperformed in 2025, with the Global X AgTech & Food Innovation ETF leading the way. Nutrien offers value with an attractive yield, improved Q4 performance, and bullish technical signals suggesting a potential rise to $70. Despite mixed Q4 results, Nutrien's positive outlook, cost-cutting efforts, and high dividend yield underscore cautious optimism and potential EPS upgrades. Key risks include retail competition, global macro weakness, geopolitical tensions, and weather impacts, but the technical breakout and valuation support a buy rating. Read the full article on Seeking AlphaDeclared Dividend • Feb 23Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2025 Payment date: 10th April 2025 Dividend yield will be 4.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (158% earnings payout ratio). However, it is covered by cash flows (77% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 76% to bring the payout ratio under control. EPS is expected to grow by 77% over the next 3 years, which should be enough to bring the dividend into a sustainable range.お知らせ • Feb 21Nutrien Ltd. Provides Sales Volume Guidance for the Year 2024Nutrien Ltd. provided sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with the global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at the North American plants. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at the White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year.Reported Earnings • Feb 20Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: US$1.36 (down from US$2.53 in FY 2023). Revenue: US$25.0b (down 11% from FY 2023). Net income: US$674.0m (down 46% from FY 2023). Profit margin: 2.7% (down from 4.5% in FY 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 1.2%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.お知らせ • Feb 20Nutrien Ltd. Declares Quarterly Dividend, Payable on April 10, 2025Nutrien Ltd. announced that its Board of Directors declared a quarterly dividend of USD 0.545 per share payable on April 10, 2025 to shareholders of record on March 31, 2025. This represents an approximately 1% increase from the prior dividend declared on November 6, 2024 and equates to an annualized dividend of USD 2.18 per share.お知らせ • Jan 31Nutrien Ltd. to Report Q4, 2024 Results on Feb 19, 2025Nutrien Ltd. announced that they will report Q4, 2024 results After-Market on Feb 19, 2025Upcoming Dividend • Dec 24Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 31 December 2024. Payment date: 17 January 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.9%. Within top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.1%).Seeking Alpha • Dec 11Nutrien: Worth Having Exposure ToSummary Nutrien Ltd. offers a strong market presence and cost advantages in potash and nitrogen, making it a compelling value despite cyclical fertilizer price volatility. The stock's 4.4% dividend yield and nearly 10% free cash flow yield provide an attractive income that is well-covered at low fertilizer prices. Nutrien's conservative capital allocation during cycles and recent performance as an inflation hedge enhance its potential to enhance risk-adjusted returns in upcoming inflation shocks. Technical analysis suggests the potential for a breakout, especially if fertilizer prices surprise to the upside; current valuation and dividend yield make it a compelling value investment. Read the full article on Seeking AlphaSeeking Alpha • Nov 12Growth On The Cheap: Nutrien's Big Yield In Fertile GroundSummary Nutrien Ltd., the world's largest potash producer, has a narrow-moat advantage, allowing profitability even when commodity prices are low. Despite recent volatility, Nutrien's 3Q24 data shows promising growth, with EBITDA up 21%, supported by higher prices and sales volumes. My investment thesis remains strong; Nutrien is a "Strong Buy" due to its cost advantages and potential for recovery in agricultural markets. Read the full article on Seeking Alphaお知らせ • Nov 12Jarden Reportedly Tapped for Incitec Pivot Fertiliser SaleIncitec Pivot Limited (ASX:IPL)'s freshly appointed management has brought in a new investment bank to handle the sale of the distribution arm of its fertiliser business as looks to clear the decks and focus on its future as a mining explosives play. The move to break up the fertiliser unit and sell off the distribution arm was first flagged by DataRoom and announced when the company delivered its annual result on 11 November 2024. It came as the company wiped $941 million off the valuation of the Australian Incitec Pivot fertiliser division. The bank being added to the ticket is Jarden. The move comes as new boss Mauro Neves de Moraes takes over. UBS and Macquarie Capital have previously made efforts to sell the fertiliser business and Macquarie still has a role. This time, though, it appears that the group is motivated to move it off its books and look to a future focused on its more successful commercial explosives operation Dyno Nobel, so it is expected to take a realistic approach to price. Former Incitec Pivot management held out for top dollar when trying to sell its fertiliser unit twice before, and opposed a business break-up. Most buyers were keen to buy the distribution arm and few were interested in taking on the more problematic manufacturing operation. But now, with distribution available separately, the sale process is likely to involve plenty of competitive tension. Australian listed trade buyers like Elders Limited (ASX:ELD) and Ridley Corporation Limited (ASX:RIC) and global strategics like The Mosaic Company (NYSE:MOS), CF Industries Holdings, Inc. (NYSE:CF) and Nutrien Ltd. (TSX:NTR), which has a major Australian presence, will be going head to head with private equity firms like Pacific Equity Partners and BGH Capital, which have been sounded out by investment bankers in recent months. It's clear the market is in favour of the decision, with shares closing higher, despite a thumping $311 million loss and an overall $1 billion writedown to the fertiliser unit. The writedown included $100m for its US operations Most of the rest was linked to the Australian manufacturing operations. The sale process will get going in earnest early next year. The book value is now $414.3 million, compared to more than $1 billion in the past. Private equity in the past has put forward offers of less than $500 million for the fertiliser business, but that was when manufacturing was also part of the picture, although they will be still keen to snap up the operation at an opportunistic price.Declared Dividend • Nov 10Third quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 31st December 2024 Payment date: 17th January 2025 Dividend yield will be 4.5%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (145% earnings payout ratio). However, it is well covered by cash flows (46% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 61% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: US$0.036 (down from US$0.15 in 3Q 2023). Revenue: US$5.09b (down 5.3% from 3Q 2023). Net income: US$18.0m (down 76% from 3Q 2023). Profit margin: 0.4% (down from 1.4% in 3Q 2023). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.お知らせ • Nov 07+ 1 more updateNutrien Ltd. Revises Operational Guidance for the Year 2024Nutrien Ltd. revised operational guidance for the year 2024. For the year, potash sales volume guidance was raised to 13.5 million tonnes to 13.9 million tonnes against previous guidance range of 13.2 million tonnes to 13.8 million tonnes due to the continued strength of global demand. The range reflects the company’s scheduled maintenance downtime in the fourth quarter and the assumption of a relatively short duration labor disruption at the Port of Vancouver. Nitrogen sales volume guidance was lowered to 10.6 million tonnes to 10.8 million tonnes against previous guidance range of 10.7 million tonnes to 11.1 million tonnes due to extended turnarounds and unplanned outages in the third quarter, including the impact of weather-related events. Phosphate sales volume guidance was lowered to 2.4 million tonnes to 2.5 million tonnes against previous guidance range of 2.5 million tonnes to 2.6 million tonnes due to weather-related production impacts in the second half of 2024.お知らせ • Oct 11Nutrien Ltd. to Report Q3, 2024 Results on Nov 06, 2024Nutrien Ltd. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024Seeking Alpha • Oct 04Nutrien: An Underappreciated Hedge Against Resurgent Supply-Side Inflation RisksSummary Fertilizer prices have stabilized to pre-COVID levels, with stocks like Nutrien trading as if the supply-chain spike never occurred. Fertilizer producers are an overlooked inflation hedge due to their strong correlation with natural gas and crop prices, with North American export demand growing. Nutrien's valuation is down, but it may be an accumulation opportunity with potential supply-side pressures seemingly rebounding. Although low domestic crop prices are a risk, Nutrien's recession exposure is low, and its correlation to the S&P 500 is very low at ~0.3X, making it a long-term alpha play. Read the full article on Seeking AlphaUpcoming Dividend • Sep 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 18 October 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.6%. Within top quartile of American dividend payers (4.3%). Higher than average of industry peers (1.9%).Seeking Alpha • Sep 15Nutrien: Short-Termism Creates Opportunities For Long-Term Investors (Rating Upgrade)Summary Nutrien's share price has continued sliding over the course of 2024, but margin and sales headwinds are weakening. The company is well-positioned to serve the high margin North America market while also expending in Latin America. At the same time, the assumptions that are built in the share price are unlikely to persist beyond the near term. Investors should be prepared for more volatility ahead, but a rating upgrade appears justified at this point in time. Read the full article on Seeking AlphaSeeking Alpha • Aug 20Nutrien Remains A 'Strong Buy' As The Tide Is TurningSummary Nutrien's stock has declined due to low crop prices, high inflation, and interest rates, but its strong financials hint at a bottoming trend. The company’s cost management and strong performance in key segments show resilience, with a positive long-term outlook driven by rising demand. Despite past struggles, I maintain a Strong Buy rating on Nutrien, confident in its potential rebound as market conditions improve. Read the full article on Seeking AlphaDeclared Dividend • Aug 11Second quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th September 2024 Payment date: 18th October 2024 Dividend yield will be 4.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (134% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 49% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.お知らせ • Aug 08Nutrien Ltd. Announces Chief Financial Officer ChangesNutrien Ltd. announces the appointment of Mark Thompson as Chief Financial Officer, effective August 26, 2024. In alignment with Nutrien's succession plan, Mr. Thompson succeeds Pedro Farah, who will remain with Nutrien in an advisory capacity until his departure on December 31, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.Reported Earnings • Aug 08Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: US$0.78 (down from US$0.89 in 2Q 2023). Revenue: US$9.92b (down 13% from 2Q 2023). Net income: US$385.0m (down 13% from 2Q 2023). Profit margin: 3.9% (in line with 2Q 2023). Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) also missed analyst estimates by 65%. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 10% per year.お知らせ • Aug 08Nutrien Ltd. Announces the Appointment of Mark Thompson as Executive Vice President, Effective August 26, 2024Nutrien Ltd. announced the appointment of Mark Thompson as Executive Vice President, effective August 26, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.Seeking Alpha • Jul 10Nutrien: We Could See A Reversal In 2024Summary Nutrien's stock price continued falling in the first half of 2024, mostly in line with agricultural commodities. At the same time, however, certain business fundamentals are showing early signs of recovery. The stock now trades at significantly more attractive levels and long-term investors should take notice. Read the full article on Seeking Alphaお知らせ • Jun 18Nutrien Ltd. to Report Q2, 2024 Results on Aug 07, 2024Nutrien Ltd. announced that they will report Q2, 2024 results on Aug 07, 2024Buy Or Sell Opportunity • Jun 11Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at US$53.20. The fair value is estimated to be US$67.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.5% over the last 3 years. Earnings per share has grown by 8.6%. For the next 3 years, revenue is forecast to grow by 1.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.Declared Dividend • May 12First quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 28th June 2024 Payment date: 19th July 2024 Dividend yield will be 3.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (124% earnings payout ratio). However, it is well covered by cash flows (37% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 38% to bring the payout ratio under control. EPS is expected to grow by 38% over the next 3 years, which should be enough to bring the dividend into a sustainable range.お知らせ • May 10Nutrien Ltd. Approves the Election of Julie A. Lagacy as DirectorNutrien Ltd. at its annual meeting of shareholders held on May 8, 2024 approved the election of Julie A. Lagacy as Director.Reported Earnings • May 09First quarter 2024 earnings: EPS misses analyst expectationsFirst quarter 2024 results: EPS: US$0.32 (down from US$1.14 in 1Q 2023). Revenue: US$5.15b (down 13% from 1Q 2023). Net income: US$158.0m (down 72% from 1Q 2023). Profit margin: 3.1% (down from 9.7% in 1Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 19%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.お知らせ • May 09Nutrien Ltd. Declares Quarterly Dividend, Payable on July 19, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.Seeking Alpha • May 06Nutrien: A Low-Risk Total Return Pick Benefiting From InflationSummary Nutrien share pricing has returned to 2018 levels, despite a stronger balance sheet and greater underlying asset value. The company offers a solid 4% dividend yield, making it an attractive choice for investors looking for both income and food-inflation hedge characteristics. With a resilient farm economy and the potential for oversized grain advances, Nutrien buyers may experience above-average total return performance over the next 3-5 years. Read the full article on Seeking Alphaお知らせ • Apr 15Nutrien Reportedly Seeks an Exit from its Retail Assets in Argentina, Chile and UruguayCanadian fertiliser giant Nutrien Ltd. (TSX:NTR) is seeking an exit from its retail assets in Argentina, Chile and Uruguay, Reuters reported citing a statement from the company. The move is said to be aimed at simplifying the company’s business and concentrating on key markets, such as Brazil.お知らせ • Apr 11Nutrien Ltd. to Report Q1, 2024 Results on May 08, 2024Nutrien Ltd. announced that they will report Q1, 2024 results After-Market on May 08, 2024Upcoming Dividend • Mar 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 March 2024. Payment date: 11 April 2024. Payout ratio is on the higher end at 84%, however this is supported by cash flows. Trailing yield: 4.0%. Lower than top quartile of American dividend payers (4.7%). Higher than average of industry peers (1.9%).Declared Dividend • Feb 25Fourth quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th March 2024 Payment date: 11th April 2024 Dividend yield will be 4.0%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (84% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 08, 2024Nutrien Ltd., Annual General Meeting, May 08, 2024.お知らせ • Feb 22Nutrien Ltd. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023Nutrien Ltd. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company recognized a $76 million non-cash impairment in Nitrogen segment relating to Trinidad property, plant and equipment due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability.Reported Earnings • Feb 22Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: US$2.53 (down from US$14.23 in FY 2022). Revenue: US$28.1b (down 24% from FY 2022). Net income: US$1.26b (down 84% from FY 2022). Profit margin: 4.5% (down from 21% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Seeking Alpha • Feb 22Nutrien: I'm Buying More Before The Market Finds Out How Cheap It IsSummary Nutrien has experienced a decline in stock price following the decrease in net earnings and adjusted EBITDA in 2023. Despite the headwinds, Nutrien remains committed to returning value to shareholders through increased dividends and share repurchases. The company anticipates higher fertilizer sales volumes and improved metrics in 2024, supported by strong potash demand and positive market conditions. Read the full article on Seeking Alphaお知らせ • Feb 22+ 1 more updateNutrien Ltd. Revises Sales Volume Guidance for the Year 2024Nutrien Ltd. revised sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.0 to 13.8 million tonnes assumes demand growth in offshore markets and a return to more normal Canpotex port operations in 2024. In North America, The company expects increased first quarter sales volumes compared to the prior year due to strong customer engagement to refill depleted inventories. Nitrogen sales volume guidance of 10.6 to 11.2 million tonnes assumes higher operating rates at US and Trinidad plants compared to 2023. Phosphate sales volume guidance of 2.6 to 2.8 million tonnes assumes improved operating rates compared to the prior year.Seeking Alpha • Feb 13Ho Ho Ho Green Giant: Nutrien Ltd. And CF Industries HoldingsSummary Soft commodities are bottoming at higher lows, leading to increased food prices. Nutrien is the largest global retailer of fertilizer and has been expanding through acquisitions. CF Industries Holdings is adjusting its business strategy and has significant cash to buy stock at depressed prices. A technical EW view of these fertilizer giants. Read the full article on Seeking Alphaお知らせ • Jan 24Nutrien Ltd. to Report Q4, 2023 Results on Feb 21, 2024Nutrien Ltd. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024Seeking Alpha • Jan 19Nutrien: Patience Will Award ShareholdersSummary Nutrien's 2023 results show a decline in gross margin and net profit compared to previous years. The company's guidance for 2023 indicates a need for approximately $2.1-2.2 billion in sustaining capital expenditures (and leases). Nutrien's long-term outlook suggests a normalized EBITDA of $7-7.5 billion per year, providing potential for higher free cash flows. Read the full article on Seeking AlphaUpcoming Dividend • Dec 21Upcoming dividend of US$0.53 per share at 3.8% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 12 January 2024. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.0%).Seeking Alpha • Nov 27Nutrien: Focus On Competitive Positioning And Capital AllocationSummary The recent drop in Nutrien Ltd.'s share price does not mean that the stock could now deliver satisfactory returns in the near term. Long-term investors should focus on evaluating the company's competitive advantages and its pricing relative to peers. Capital allocation is another key area of consideration for anyone willing to hold in the long run. Even after falling more than 50% from its all-time highs, I still see Nutrien as a hold within a well-diversified portfolio. Read the full article on Seeking AlphaSeeking Alpha • Nov 06Deep Value - Why Nutrien Remains Significantly UndervaluedSummary Nutrien's stock has declined by 25% this year, but its fundamentals remain strong with good earnings and upgraded guidance. The company sees strong demand, higher fertilizer affordability, and geopolitical tailwinds that could stabilize earnings. Global grain yields are projected to fall, which could benefit crop prices and fertilizer demand. Read the full article on Seeking AlphaReported Earnings • Nov 02Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: US$0.15 (down from US$2.95 in 3Q 2022). Revenue: US$5.37b (down 33% from 3Q 2022). Net income: US$75.0m (down 95% from 3Q 2022). Profit margin: 1.4% (down from 20% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.4%. Earnings per share (EPS) also missed analyst estimates by 72%. Revenue is forecast to stay flat during the next 3 years compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 02Nutrien Ltd. Declares Quarterly Dividend, Payable on January 12, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.53 per share payable on January 12, 2024, to shareholders of record on December 29, 2023.お知らせ • Oct 06Nutrien Ltd. to Report Q3, 2023 Results on Nov 01, 2023Nutrien Ltd. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023Seeking Alpha • Sep 27Nutrien: Waiting For Market Fundamentals To ImproveSummary Nutrien Ltd. has revised its guidance for 2023, with expected EBITDA nearly 15% lower than previously anticipated. The deteriorating pricing environment in the agricultural sector is the main reason for the downward revision. Holding a neutral stance on NTR and considering other options like Corteva and The Mosaic Company for exposure to the fertilizer industry. Read the full article on Seeking Alpha配当金の支払いについて今日Jun 11 2026配当落ち日Jun 30 2026配当支払日Jul 17 202617 days 配当落ちから次の19 days 、次の配当を受け取るために購入する。決済の安定と成長配当データの取得安定した配当: 配当金の支払いは安定していますが、 NTRが配当金を支払っている期間は 10 年未満です。増加する配当: NTRの配当金は増加していますが、同社は8年間しか配当金を支払っていません。配当利回り対市場Nutrien 配当利回り対市場NTR 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (NTR)3.4%市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Chemicals)1.7%アナリスト予想 (NTR) (最長3年)3.5%注目すべき配当: NTRの配当金 ( 3.38% ) はUS市場の配当金支払者の下位 25% ( 1.41% ) よりも高くなっています。高配当: NTRの配当金 ( 3.38% ) はUS市場の配当金支払者の上位 25% ( 4.24% ) と比較すると低いです。株主への利益配当収益カバレッジ: NTRの 配当性向 ( 44.3% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: NTRの 現金配当性向 ( 47.8% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/10 06:28終値2026/06/10 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Nutrien Ltd. 15 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。52 アナリスト機関Harriet LiAccountability Research CorporationKeith CarpenterATB CormarkBenjamin TheurerBarclays49 その他のアナリストを表示
Declared Dividend • May 11First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2026 Payment date: 17th July 2026 Dividend yield will be 3.2%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 15% over the next 3 years. However, it would need to fall by 51% to increase the payout ratio to a potentially unsustainable range.
Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 16 April 2026. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (1.8%).
Declared Dividend • Feb 22Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2026 Payment date: 16th April 2026 Dividend yield will be 3.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (47% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 5.2% over the next 3 years. However, it would need to fall by 48% to increase the payout ratio to a potentially unsustainable range.
Upcoming Dividend • Sep 22Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 17 October 2025. Payout ratio is on the higher end at 78%, however this is supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (2.0%).
Declared Dividend • Aug 10Second quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 29th September 2025 Payment date: 17th October 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 33% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Aug 07+ 1 more updateNutrien Declares Quarterly Dividend, Payable on October 17, 2025Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025.
Buy Or Sell Opportunity • Jun 05Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to US$67.20. The fair value is estimated to be US$84.66, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.3% over the last 3 years. Earnings per share has declined by 37%. For the next 3 years, revenue is forecast to grow by 0.3% per annum. Earnings are forecast to decline by 6.9% per annum over the same time period.
Recent Insider Transactions • May 14Independent Director recently bought US$999k worth of stockOn the 8th of May, Aaron Regent bought around 14k shares on-market at roughly US$68.93 per share. This transaction amounted to 61% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$2.0m more in shares than they have sold in the last 12 months.
Declared Dividend • May 11First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2026 Payment date: 17th July 2026 Dividend yield will be 3.2%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 15% over the next 3 years. However, it would need to fall by 51% to increase the payout ratio to a potentially unsustainable range.
Seeking Alpha • May 10Nutrien: Fertilizer Demand Isn't Going Anywhere, And The Market Is Undervaluing ItSummary Nutrien is mispriced as the market overweights European sustainability policy, ignoring surging synthetic fertilizer demand in emerging markets. NTR's integrated model, record 2025 EBITDA of $6.05B, and 14x forward P/E position it for structural demand growth, not decline. Key catalysts include Q1 2026 earnings, potash price stabilization, and continued retail expansion in Brazil and other developing regions. Risks include fertilizer price volatility, natural gas cost swings, and execution risk in emerging markets, particularly Brazil. Read the full article on Seeking Alpha
Reported Earnings • May 07First quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2026 results: EPS: US$0.27 (up from US$0.022 in 1Q 2025). Revenue: US$5.80b (up 19% from 1Q 2025). Net income: US$131.0m (up US$120.0m from 1Q 2025). Profit margin: 2.3% (up from 0.2% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.7%. Earnings per share (EPS) missed analyst estimates by 47%. Revenue is forecast to stay flat during the next 3 years compared to a 5.2% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Buy Or Sell Opportunity • May 06Now 23% undervaluedOver the last 90 days, the stock has risen 8.6% to US$73.81. The fair value is estimated to be US$96.05, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 2.1% per annum over the same time period.
お知らせ • Apr 10Nutrien Ltd. to Report Q1, 2026 Results on May 06, 2026Nutrien Ltd. announced that they will report Q1, 2026 results After-Market on May 06, 2026
Buy Or Sell Opportunity • Apr 08Now 21% undervaluedOver the last 90 days, the stock has risen 25% to US$74.88. The fair value is estimated to be US$94.95, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.1% per annum. Earnings are forecast to decline by 1.9% per annum over the same time period.
Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2026. Payment date: 16 April 2026. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 2.9%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (1.8%).
Buy Or Sell Opportunity • Mar 20Now 20% undervaluedOver the last 90 days, the stock has risen 20% to US$74.73. The fair value is estimated to be US$93.65, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.0% per annum. Earnings are forecast to decline by 0.9% per annum over the same time period.
New Risk • Mar 18New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
Recent Insider Transactions • Mar 17Insider recently sold US$403k worth of stockOn the 11th of March, Christopher Reynolds sold around 5k shares on-market at roughly US$83.96 per share. This transaction amounted to 37% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$328k more than they sold in the last 12 months.
New Risk • Mar 13New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 1.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company.
Buy Or Sell Opportunity • Mar 04Now 21% undervaluedOver the last 90 days, the stock has risen 23% to US$73.59. The fair value is estimated to be US$92.91, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 64%. For the next 3 years, revenue is forecast to grow by 1.6% per annum. Earnings are forecast to decline by 0.02% per annum over the same time period.
お知らせ • Feb 23Nutrien Ltd., Annual General Meeting, May 06, 2026Nutrien Ltd., Annual General Meeting, May 06, 2026.
Declared Dividend • Feb 22Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2026 Payment date: 16th April 2026 Dividend yield will be 3.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (47% earnings payout ratio) and cash flows (53% cash payout ratio). The dividend has increased by an average of 4.1% per year over the past 8 years and payments have been stable during that time. EPS is expected to decline by 5.2% over the next 3 years. However, it would need to fall by 48% to increase the payout ratio to a potentially unsustainable range.
Reported Earnings • Feb 19Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: US$4.66 (up from US$1.36 in FY 2024). Revenue: US$25.9b (up 3.7% from FY 2024). Net income: US$2.27b (up 236% from FY 2024). Profit margin: 8.7% (up from 2.7% in FY 2024). The increase in margin was primarily driven by higher revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 9.0%. Revenue is forecast to grow 1.3% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 19+ 1 more updateNutrien Ltd. Provides Operating Guidance for the Fiscal Year 2026Nutrien Ltd. provided operating guidance for the fiscal year 2026. For the year, the company expects,Potash sales volume guidance of 14.1 million tonnes to 14.8 million tonnes is consistent with our global shipment expectation. Nitrogen sales volume guidance of 9.2 million tonnes to 9.7 million tonnes assumes no production from our Trinidad and New Madrid facility, which accounted for approximately 1.4 million tonnes and 0.2 million tonnes, respectively, in 2025. Nitrogen sales volumes are supported by planned reliability improvements and debottlenecks. Phosphate sales volume guidance of 2.4 million tonnes to 2.6 million tonnes reflect the benefits of reliability improvement initiatives completed in 2025.
New Risk • Feb 04New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.5% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.5% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity).
New Risk • Jan 21New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 0.6% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.6% per year for the foreseeable future. Minor Risk High level of debt (49% net debt to equity).
Board Change • Jan 21Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 21Nutrien Ltd. to Report Q4, 2025 Results on Feb 18, 2026Nutrien Ltd. announced that they will report Q4, 2025 results After-Market on Feb 18, 2026
お知らせ • Dec 12Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR).Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd. Adecoagro S.A. (NYSE:AGRO) completed the acquisition of 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) on December 10, 2025.
お知らせ • Nov 06+ 1 more updateNutrien Ltd. Revises Operating Guidance for the Fiscal Year 2025Nutrien Ltd. revised operating guidance for the fiscal year 2025. For the year, the company expects Potash sales volumes to be in the range of 14 million tonnes to 14.5 million tonnes compared to previous guidance of 13.9 million tonnes to 14.5 million tonnes. Nitrogen sales volumes to be in the range of 10.7 million tonnes to 11 million tonnes compared to previous guidance of 10.7 million tonnes to 11.2 million tonnes. Phosphate sales volumes to be in the range of 2.35 million tonnes to 2.55 million tonnes compared to previous guidance of 2.35 million tonnes to 2.55 million tonnes.
お知らせ • Oct 22+ 1 more updateNutrien Ltd. Commences A Controlled Shut Down of Its Trinidad Nitrogen OperationsNutrien Ltd. announced that it has commenced a controlled shut down of its Trinidad Nitrogen operations at the Point Lisas' facility to be effective October 23, 2025. This shutdown is in response to port access restrictions imposed by Trinidad and Tobago's National Energy Corporation (NEC) and a lack of reliable and economic natural gas supply that has reduced the free cash flow contribution of the Trinidad Nitrogen operations over an extended period of time. Nutrien will continue to engage with stakeholders and assess options with respect to its operations in Trinidad. Ammonia and urea sales volumes from Nutrien's Trinidad operations are approximately 85 and 55 thousand tonnes per month, respectively. Nutrien expects to be within its 2025 annual nitrogen sales volume guidance range of 10.7 to 11.2 million tonnes due to the continued strong performance of its North American Nitrogen operations.
Buy Or Sell Opportunity • Oct 16Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 6.0% to US$56.42. The fair value is estimated to be US$71.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Earnings per share has declined by 82%. For the next 3 years, revenue is forecast to grow by 2.2% per annum. Earnings are also forecast to grow by 14% per annum over the same time period.
お知らせ • Oct 07Nutrien Ltd. to Report Q3, 2025 Results on Nov 05, 2025Nutrien Ltd. announced that they will report Q3, 2025 results at 4:00 PM, US Eastern Standard Time on Nov 05, 2025
Upcoming Dividend • Sep 22Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 17 October 2025. Payout ratio is on the higher end at 78%, however this is supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.4%). Higher than average of industry peers (2.0%).
お知らせ • Sep 09Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million.Adecoagro S.A. (NYSE:AGRO) signed an agreement to acquire 50% stake in PROFERTIL S.A. from Nutrien Ltd. (TSX:NTR) for approximately $600 million on September 8, 2025. The transaction is subject to customary closing conditions and is expected to be completed before the end of 2025. Rabo Trading Argentina SA acted as financial advisor for Adecoagro S.A. BofA Securities, Inc. acted as financial advisor for Nutrien Ltd.
Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. Independent Director Julie Lagacy was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Declared Dividend • Aug 10Second quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 29th September 2025 Payment date: 17th October 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (78% earnings payout ratio) and cash flows (63% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. EPS is expected to grow by 33% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Aug 07Second quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2025 results: EPS: US$2.51 (up from US$0.78 in 2Q 2024). Revenue: US$10.2b (up 2.8% from 2Q 2024). Net income: US$1.22b (up 217% from 2Q 2024). Profit margin: 12% (up from 3.9% in 2Q 2024). The increase in margin was primarily driven by lower expenses. Revenue missed analyst estimates by 2.4%. Earnings per share (EPS) exceeded analyst estimates by 10%. Revenue is forecast to grow 2.2% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 67 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 07+ 1 more updateNutrien Declares Quarterly Dividend, Payable on October 17, 2025Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.545 per share payable on October 17, 2025, to shareholders of record on September 29, 2025.
Buy Or Sell Opportunity • Aug 06Now 20% undervaluedOver the last 90 days, the stock has risen 5.8% to US$57.95. The fair value is estimated to be US$72.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 13% over the last 3 years. Earnings per share has declined by 73%. For the next 3 years, revenue is forecast to grow by 2.4% per annum. Earnings are also forecast to grow by 23% per annum over the same time period.
お知らせ • Jul 10Nutrien Ltd. to Report Q2, 2025 Results on Aug 06, 2025Nutrien Ltd. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025
Upcoming Dividend • Jun 23Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 30 June 2025. Payment date: 18 July 2025. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 3.6%. Lower than top quartile of American dividend payers (4.8%). Higher than average of industry peers (2.2%).
Declared Dividend • May 11First quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 30th June 2025 Payment date: 18th July 2025 Dividend yield will be 3.9%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (202% earnings payout ratio) nor is it covered by cash flows (127% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 125% to bring the payout ratio under control. EPS is expected to grow by 108% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
New Risk • May 09New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Dividend yield: 3.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 202% Cash payout ratio: 127% Minor Risks High level of debt (52% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.1% net profit margin).
Reported Earnings • May 08First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: US$0.022 (down from US$0.32 in 1Q 2024). Revenue: US$4.87b (down 5.4% from 1Q 2024). Net income: US$11.0m (down 93% from 1Q 2024). Profit margin: 0.2% (down from 3.1% in 1Q 2024). Revenue missed analyst estimates by 5.3%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 3.3% p.a. on average during the next 3 years, compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
お知らせ • May 08+ 1 more updateNutrien Ltd. Provides Operation Guidance for the Year 2025Nutrien Ltd. provided operation guidance for the year 2025. For the year, the company provided Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with its historical share of global shipments. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes reliability improvements and higher operating rates at its North American plants compared to 2024. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production in the first half of 2025 and improved operating rates in the second half compared to the prior year.
お知らせ • Apr 16Nutrien Ltd. to Report Q1, 2025 Results on May 07, 2025Nutrien Ltd. announced that they will report Q1, 2025 results After-Market on May 07, 2025
Upcoming Dividend • Mar 24Upcoming dividend of US$0.55 per shareEligible shareholders must have bought the stock before 31 March 2025. Payment date: 10 April 2025. The company is paying out more than 100% of its profits and is paying out 77% of its cash flow. Trailing yield: 4.2%. Lower than top quartile of American dividend payers (4.7%). Higher than average of industry peers (2.2%).
お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 07, 2025Nutrien Ltd., Annual General Meeting, May 07, 2025.
Seeking Alpha • Feb 24Nutrien: The Downtrend Is Done, Dividend Hike And Technicals Are EvidenceSummary The Materials sector, particularly the agricultural industry, has outperformed in 2025, with the Global X AgTech & Food Innovation ETF leading the way. Nutrien offers value with an attractive yield, improved Q4 performance, and bullish technical signals suggesting a potential rise to $70. Despite mixed Q4 results, Nutrien's positive outlook, cost-cutting efforts, and high dividend yield underscore cautious optimism and potential EPS upgrades. Key risks include retail competition, global macro weakness, geopolitical tensions, and weather impacts, but the technical breakout and valuation support a buy rating. Read the full article on Seeking Alpha
Declared Dividend • Feb 23Fourth quarter dividend of US$0.55 announcedShareholders will receive a dividend of US$0.55. Ex-date: 31st March 2025 Payment date: 10th April 2025 Dividend yield will be 4.1%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (158% earnings payout ratio). However, it is covered by cash flows (77% cash payout ratio). The dividend has increased by an average of 4.5% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 76% to bring the payout ratio under control. EPS is expected to grow by 77% over the next 3 years, which should be enough to bring the dividend into a sustainable range.
お知らせ • Feb 21Nutrien Ltd. Provides Sales Volume Guidance for the Year 2024Nutrien Ltd. provided sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with the global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability. Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at the North American plants. Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at the White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year.
Reported Earnings • Feb 20Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: US$1.36 (down from US$2.53 in FY 2023). Revenue: US$25.0b (down 11% from FY 2023). Net income: US$674.0m (down 46% from FY 2023). Profit margin: 2.7% (down from 4.5% in FY 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 1.2%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 20Nutrien Ltd. Declares Quarterly Dividend, Payable on April 10, 2025Nutrien Ltd. announced that its Board of Directors declared a quarterly dividend of USD 0.545 per share payable on April 10, 2025 to shareholders of record on March 31, 2025. This represents an approximately 1% increase from the prior dividend declared on November 6, 2024 and equates to an annualized dividend of USD 2.18 per share.
お知らせ • Jan 31Nutrien Ltd. to Report Q4, 2024 Results on Feb 19, 2025Nutrien Ltd. announced that they will report Q4, 2024 results After-Market on Feb 19, 2025
Upcoming Dividend • Dec 24Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 31 December 2024. Payment date: 17 January 2025. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.9%. Within top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.1%).
Seeking Alpha • Dec 11Nutrien: Worth Having Exposure ToSummary Nutrien Ltd. offers a strong market presence and cost advantages in potash and nitrogen, making it a compelling value despite cyclical fertilizer price volatility. The stock's 4.4% dividend yield and nearly 10% free cash flow yield provide an attractive income that is well-covered at low fertilizer prices. Nutrien's conservative capital allocation during cycles and recent performance as an inflation hedge enhance its potential to enhance risk-adjusted returns in upcoming inflation shocks. Technical analysis suggests the potential for a breakout, especially if fertilizer prices surprise to the upside; current valuation and dividend yield make it a compelling value investment. Read the full article on Seeking Alpha
Seeking Alpha • Nov 12Growth On The Cheap: Nutrien's Big Yield In Fertile GroundSummary Nutrien Ltd., the world's largest potash producer, has a narrow-moat advantage, allowing profitability even when commodity prices are low. Despite recent volatility, Nutrien's 3Q24 data shows promising growth, with EBITDA up 21%, supported by higher prices and sales volumes. My investment thesis remains strong; Nutrien is a "Strong Buy" due to its cost advantages and potential for recovery in agricultural markets. Read the full article on Seeking Alpha
お知らせ • Nov 12Jarden Reportedly Tapped for Incitec Pivot Fertiliser SaleIncitec Pivot Limited (ASX:IPL)'s freshly appointed management has brought in a new investment bank to handle the sale of the distribution arm of its fertiliser business as looks to clear the decks and focus on its future as a mining explosives play. The move to break up the fertiliser unit and sell off the distribution arm was first flagged by DataRoom and announced when the company delivered its annual result on 11 November 2024. It came as the company wiped $941 million off the valuation of the Australian Incitec Pivot fertiliser division. The bank being added to the ticket is Jarden. The move comes as new boss Mauro Neves de Moraes takes over. UBS and Macquarie Capital have previously made efforts to sell the fertiliser business and Macquarie still has a role. This time, though, it appears that the group is motivated to move it off its books and look to a future focused on its more successful commercial explosives operation Dyno Nobel, so it is expected to take a realistic approach to price. Former Incitec Pivot management held out for top dollar when trying to sell its fertiliser unit twice before, and opposed a business break-up. Most buyers were keen to buy the distribution arm and few were interested in taking on the more problematic manufacturing operation. But now, with distribution available separately, the sale process is likely to involve plenty of competitive tension. Australian listed trade buyers like Elders Limited (ASX:ELD) and Ridley Corporation Limited (ASX:RIC) and global strategics like The Mosaic Company (NYSE:MOS), CF Industries Holdings, Inc. (NYSE:CF) and Nutrien Ltd. (TSX:NTR), which has a major Australian presence, will be going head to head with private equity firms like Pacific Equity Partners and BGH Capital, which have been sounded out by investment bankers in recent months. It's clear the market is in favour of the decision, with shares closing higher, despite a thumping $311 million loss and an overall $1 billion writedown to the fertiliser unit. The writedown included $100m for its US operations Most of the rest was linked to the Australian manufacturing operations. The sale process will get going in earnest early next year. The book value is now $414.3 million, compared to more than $1 billion in the past. Private equity in the past has put forward offers of less than $500 million for the fertiliser business, but that was when manufacturing was also part of the picture, although they will be still keen to snap up the operation at an opportunistic price.
Declared Dividend • Nov 10Third quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 31st December 2024 Payment date: 17th January 2025 Dividend yield will be 4.5%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (145% earnings payout ratio). However, it is well covered by cash flows (46% cash payout ratio). The dividend has increased by an average of 4.4% per year over the past 7 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 61% to bring the payout ratio under control. EPS is expected to grow by 68% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
Reported Earnings • Nov 07Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: US$0.036 (down from US$0.15 in 3Q 2023). Revenue: US$5.09b (down 5.3% from 3Q 2023). Net income: US$18.0m (down 76% from 3Q 2023). Profit margin: 0.4% (down from 1.4% in 3Q 2023). Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) also missed analyst estimates by 91%. Revenue is forecast to grow 2.9% p.a. on average during the next 3 years, compared to a 4.6% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
お知らせ • Nov 07+ 1 more updateNutrien Ltd. Revises Operational Guidance for the Year 2024Nutrien Ltd. revised operational guidance for the year 2024. For the year, potash sales volume guidance was raised to 13.5 million tonnes to 13.9 million tonnes against previous guidance range of 13.2 million tonnes to 13.8 million tonnes due to the continued strength of global demand. The range reflects the company’s scheduled maintenance downtime in the fourth quarter and the assumption of a relatively short duration labor disruption at the Port of Vancouver. Nitrogen sales volume guidance was lowered to 10.6 million tonnes to 10.8 million tonnes against previous guidance range of 10.7 million tonnes to 11.1 million tonnes due to extended turnarounds and unplanned outages in the third quarter, including the impact of weather-related events. Phosphate sales volume guidance was lowered to 2.4 million tonnes to 2.5 million tonnes against previous guidance range of 2.5 million tonnes to 2.6 million tonnes due to weather-related production impacts in the second half of 2024.
お知らせ • Oct 11Nutrien Ltd. to Report Q3, 2024 Results on Nov 06, 2024Nutrien Ltd. announced that they will report Q3, 2024 results After-Market on Nov 06, 2024
Seeking Alpha • Oct 04Nutrien: An Underappreciated Hedge Against Resurgent Supply-Side Inflation RisksSummary Fertilizer prices have stabilized to pre-COVID levels, with stocks like Nutrien trading as if the supply-chain spike never occurred. Fertilizer producers are an overlooked inflation hedge due to their strong correlation with natural gas and crop prices, with North American export demand growing. Nutrien's valuation is down, but it may be an accumulation opportunity with potential supply-side pressures seemingly rebounding. Although low domestic crop prices are a risk, Nutrien's recession exposure is low, and its correlation to the S&P 500 is very low at ~0.3X, making it a long-term alpha play. Read the full article on Seeking Alpha
Upcoming Dividend • Sep 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 18 October 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 4.6%. Within top quartile of American dividend payers (4.3%). Higher than average of industry peers (1.9%).
Seeking Alpha • Sep 15Nutrien: Short-Termism Creates Opportunities For Long-Term Investors (Rating Upgrade)Summary Nutrien's share price has continued sliding over the course of 2024, but margin and sales headwinds are weakening. The company is well-positioned to serve the high margin North America market while also expending in Latin America. At the same time, the assumptions that are built in the share price are unlikely to persist beyond the near term. Investors should be prepared for more volatility ahead, but a rating upgrade appears justified at this point in time. Read the full article on Seeking Alpha
Seeking Alpha • Aug 20Nutrien Remains A 'Strong Buy' As The Tide Is TurningSummary Nutrien's stock has declined due to low crop prices, high inflation, and interest rates, but its strong financials hint at a bottoming trend. The company’s cost management and strong performance in key segments show resilience, with a positive long-term outlook driven by rising demand. Despite past struggles, I maintain a Strong Buy rating on Nutrien, confident in its potential rebound as market conditions improve. Read the full article on Seeking Alpha
Declared Dividend • Aug 11Second quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th September 2024 Payment date: 18th October 2024 Dividend yield will be 4.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (134% earnings payout ratio). However, it is well covered by cash flows (40% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 49% to bring the payout ratio under control. EPS is expected to grow by 56% over the next 3 years, which is sufficient to bring the dividend into a sustainable range.
お知らせ • Aug 08Nutrien Ltd. Announces Chief Financial Officer ChangesNutrien Ltd. announces the appointment of Mark Thompson as Chief Financial Officer, effective August 26, 2024. In alignment with Nutrien's succession plan, Mr. Thompson succeeds Pedro Farah, who will remain with Nutrien in an advisory capacity until his departure on December 31, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.
Reported Earnings • Aug 08Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: US$0.78 (down from US$0.89 in 2Q 2023). Revenue: US$9.92b (down 13% from 2Q 2023). Net income: US$385.0m (down 13% from 2Q 2023). Profit margin: 3.9% (in line with 2Q 2023). Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) also missed analyst estimates by 65%. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year whereas the company’s share price has fallen by 10% per year.
お知らせ • Aug 08Nutrien Ltd. Announces the Appointment of Mark Thompson as Executive Vice President, Effective August 26, 2024Nutrien Ltd. announced the appointment of Mark Thompson as Executive Vice President, effective August 26, 2024. Mr. Thompson has been with the Company since 2011, currently serving as Executive Vice President and Chief Commercial Officer. Prior to his current position he held numerous executive and senior leadership roles across the company, including Chief Strategy & Sustainability Officer, Chief Corporate Development & Strategy Officer, and Vice President of Business Development for Nutrien’s Retail business. He earned his Bachelor of Commerce (Finance) and Bachelor of Arts degrees from the University of Saskatchewan and holds the Chartered Financial Analyst (CFA) designation.
Seeking Alpha • Jul 10Nutrien: We Could See A Reversal In 2024Summary Nutrien's stock price continued falling in the first half of 2024, mostly in line with agricultural commodities. At the same time, however, certain business fundamentals are showing early signs of recovery. The stock now trades at significantly more attractive levels and long-term investors should take notice. Read the full article on Seeking Alpha
お知らせ • Jun 18Nutrien Ltd. to Report Q2, 2024 Results on Aug 07, 2024Nutrien Ltd. announced that they will report Q2, 2024 results on Aug 07, 2024
Buy Or Sell Opportunity • Jun 11Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at US$53.20. The fair value is estimated to be US$67.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 9.5% over the last 3 years. Earnings per share has grown by 8.6%. For the next 3 years, revenue is forecast to grow by 1.9% per annum. Earnings are also forecast to grow by 16% per annum over the same time period.
Declared Dividend • May 12First quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 28th June 2024 Payment date: 19th July 2024 Dividend yield will be 3.7%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is not covered by earnings (124% earnings payout ratio). However, it is well covered by cash flows (37% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. The company's earnings per share (EPS) would need to grow by 38% to bring the payout ratio under control. EPS is expected to grow by 38% over the next 3 years, which should be enough to bring the dividend into a sustainable range.
お知らせ • May 10Nutrien Ltd. Approves the Election of Julie A. Lagacy as DirectorNutrien Ltd. at its annual meeting of shareholders held on May 8, 2024 approved the election of Julie A. Lagacy as Director.
Reported Earnings • May 09First quarter 2024 earnings: EPS misses analyst expectationsFirst quarter 2024 results: EPS: US$0.32 (down from US$1.14 in 1Q 2023). Revenue: US$5.15b (down 13% from 1Q 2023). Net income: US$158.0m (down 72% from 1Q 2023). Profit margin: 3.1% (down from 9.7% in 1Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 19%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
お知らせ • May 09Nutrien Ltd. Declares Quarterly Dividend, Payable on July 19, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.54 per share payable on July 19, 2024, to shareholders of record on June 28, 2024.
Seeking Alpha • May 06Nutrien: A Low-Risk Total Return Pick Benefiting From InflationSummary Nutrien share pricing has returned to 2018 levels, despite a stronger balance sheet and greater underlying asset value. The company offers a solid 4% dividend yield, making it an attractive choice for investors looking for both income and food-inflation hedge characteristics. With a resilient farm economy and the potential for oversized grain advances, Nutrien buyers may experience above-average total return performance over the next 3-5 years. Read the full article on Seeking Alpha
お知らせ • Apr 15Nutrien Reportedly Seeks an Exit from its Retail Assets in Argentina, Chile and UruguayCanadian fertiliser giant Nutrien Ltd. (TSX:NTR) is seeking an exit from its retail assets in Argentina, Chile and Uruguay, Reuters reported citing a statement from the company. The move is said to be aimed at simplifying the company’s business and concentrating on key markets, such as Brazil.
お知らせ • Apr 11Nutrien Ltd. to Report Q1, 2024 Results on May 08, 2024Nutrien Ltd. announced that they will report Q1, 2024 results After-Market on May 08, 2024
Upcoming Dividend • Mar 20Upcoming dividend of US$0.54 per shareEligible shareholders must have bought the stock before 27 March 2024. Payment date: 11 April 2024. Payout ratio is on the higher end at 84%, however this is supported by cash flows. Trailing yield: 4.0%. Lower than top quartile of American dividend payers (4.7%). Higher than average of industry peers (1.9%).
Declared Dividend • Feb 25Fourth quarter dividend of US$0.54 announcedShareholders will receive a dividend of US$0.54. Ex-date: 27th March 2024 Payment date: 11th April 2024 Dividend yield will be 4.0%, which is higher than the industry average of 2.0%. Sustainability & Growth Dividend is covered by both earnings (84% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 5.1% per year over the past 6 years and payments have been stable during that time. EPS is expected to grow by 34% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Feb 24Nutrien Ltd., Annual General Meeting, May 08, 2024Nutrien Ltd., Annual General Meeting, May 08, 2024.
お知らせ • Feb 22Nutrien Ltd. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023Nutrien Ltd. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company recognized a $76 million non-cash impairment in Nitrogen segment relating to Trinidad property, plant and equipment due to a new natural gas contract and the resulting outlook for higher expected natural gas costs and constrained near-term availability.
Reported Earnings • Feb 22Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: US$2.53 (down from US$14.23 in FY 2022). Revenue: US$28.1b (down 24% from FY 2022). Net income: US$1.26b (down 84% from FY 2022). Profit margin: 4.5% (down from 21% in FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 25%. Revenue is forecast to stay flat during the next 3 years compared to a 4.4% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Seeking Alpha • Feb 22Nutrien: I'm Buying More Before The Market Finds Out How Cheap It IsSummary Nutrien has experienced a decline in stock price following the decrease in net earnings and adjusted EBITDA in 2023. Despite the headwinds, Nutrien remains committed to returning value to shareholders through increased dividends and share repurchases. The company anticipates higher fertilizer sales volumes and improved metrics in 2024, supported by strong potash demand and positive market conditions. Read the full article on Seeking Alpha
お知らせ • Feb 22+ 1 more updateNutrien Ltd. Revises Sales Volume Guidance for the Year 2024Nutrien Ltd. revised sales volume guidance for the year 2024. For the year, the company expects Potash sales volume guidance of 13.0 to 13.8 million tonnes assumes demand growth in offshore markets and a return to more normal Canpotex port operations in 2024. In North America, The company expects increased first quarter sales volumes compared to the prior year due to strong customer engagement to refill depleted inventories. Nitrogen sales volume guidance of 10.6 to 11.2 million tonnes assumes higher operating rates at US and Trinidad plants compared to 2023. Phosphate sales volume guidance of 2.6 to 2.8 million tonnes assumes improved operating rates compared to the prior year.
Seeking Alpha • Feb 13Ho Ho Ho Green Giant: Nutrien Ltd. And CF Industries HoldingsSummary Soft commodities are bottoming at higher lows, leading to increased food prices. Nutrien is the largest global retailer of fertilizer and has been expanding through acquisitions. CF Industries Holdings is adjusting its business strategy and has significant cash to buy stock at depressed prices. A technical EW view of these fertilizer giants. Read the full article on Seeking Alpha
お知らせ • Jan 24Nutrien Ltd. to Report Q4, 2023 Results on Feb 21, 2024Nutrien Ltd. announced that they will report Q4, 2023 results After-Market on Feb 21, 2024
Seeking Alpha • Jan 19Nutrien: Patience Will Award ShareholdersSummary Nutrien's 2023 results show a decline in gross margin and net profit compared to previous years. The company's guidance for 2023 indicates a need for approximately $2.1-2.2 billion in sustaining capital expenditures (and leases). Nutrien's long-term outlook suggests a normalized EBITDA of $7-7.5 billion per year, providing potential for higher free cash flows. Read the full article on Seeking Alpha
Upcoming Dividend • Dec 21Upcoming dividend of US$0.53 per share at 3.8% yieldEligible shareholders must have bought the stock before 28 December 2023. Payment date: 12 January 2024. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 3.8%. Lower than top quartile of American dividend payers (4.5%). Higher than average of industry peers (2.0%).
Seeking Alpha • Nov 27Nutrien: Focus On Competitive Positioning And Capital AllocationSummary The recent drop in Nutrien Ltd.'s share price does not mean that the stock could now deliver satisfactory returns in the near term. Long-term investors should focus on evaluating the company's competitive advantages and its pricing relative to peers. Capital allocation is another key area of consideration for anyone willing to hold in the long run. Even after falling more than 50% from its all-time highs, I still see Nutrien as a hold within a well-diversified portfolio. Read the full article on Seeking Alpha
Seeking Alpha • Nov 06Deep Value - Why Nutrien Remains Significantly UndervaluedSummary Nutrien's stock has declined by 25% this year, but its fundamentals remain strong with good earnings and upgraded guidance. The company sees strong demand, higher fertilizer affordability, and geopolitical tailwinds that could stabilize earnings. Global grain yields are projected to fall, which could benefit crop prices and fertilizer demand. Read the full article on Seeking Alpha
Reported Earnings • Nov 02Third quarter 2023 earnings: EPS and revenues miss analyst expectationsThird quarter 2023 results: EPS: US$0.15 (down from US$2.95 in 3Q 2022). Revenue: US$5.37b (down 33% from 3Q 2022). Net income: US$75.0m (down 95% from 3Q 2022). Profit margin: 1.4% (down from 20% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.4%. Earnings per share (EPS) also missed analyst estimates by 72%. Revenue is forecast to stay flat during the next 3 years compared to a 4.1% growth forecast for the Chemicals industry in the US. Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 02Nutrien Ltd. Declares Quarterly Dividend, Payable on January 12, 2024Nutrien Ltd. announced that its Board of Directors has declared a quarterly dividend of USD 0.53 per share payable on January 12, 2024, to shareholders of record on December 29, 2023.
お知らせ • Oct 06Nutrien Ltd. to Report Q3, 2023 Results on Nov 01, 2023Nutrien Ltd. announced that they will report Q3, 2023 results After-Market on Nov 01, 2023
Seeking Alpha • Sep 27Nutrien: Waiting For Market Fundamentals To ImproveSummary Nutrien Ltd. has revised its guidance for 2023, with expected EBITDA nearly 15% lower than previously anticipated. The deteriorating pricing environment in the agricultural sector is the main reason for the downward revision. Holding a neutral stance on NTR and considering other options like Corteva and The Mosaic Company for exposure to the fertilizer industry. Read the full article on Seeking Alpha